Vision changes are listed as a potential Ozempic side effect, though the label notes the blurred vision is possibly caused by hypoglycemia (low blood sugar)
Alvarez E, Martinez MD, Roncero I, Chowen JA, Garcia-Cuartero B, Gispert JD, et al
The transition from phentermine to GLP-1 is well-established in clinical practice, and patients who responded well to appetite suppression on phentermine typically respond even better to GLP-1 medications
GSH is also essential to aerobic muscular contraction, so competition between the immune and muscular systems for GSH precursors may subsequently develop
It's important to note that whilst Ozempic is licensed specifically for type 2 diabetes, a higher-dose formulation of semaglutide (Wegovy) has been approved by the MHRA for weight management in adults with obesity or overweight with weight-related comorbidities